Respiratory

Back to articles

Inhaled Tobramycin Improves Lung Function in Adolescent Patients with Cystic Fibrosis

KEY POINT

Long-term suppression of Pseudomonas aeruginosa is needed in patients with cystic fibrosis, and a recent study supports use of intermittent inhaled tobramycin for accomplishing it.

SOURCES

Moss RB. Long-term benefits of inhaled tobramycin in adolescent patients with cystic fibrosis. Chest. 2002;121:55–63.